Development and Validation of a Diabetic Retinopathy Risk Stratification Algorithm
Open accessAbstract
OBJECTIVE: Although diabetic retinopathy is a leading cause of blindness worldwide, diabetes-related blindness can be prevented through effective screening, detection, and treatment of disease. The study goal was to develop risk stratification algorithms for the onset of retinal complications of diabetes, including proliferative diabetic retinopathy, referable retinopathy, and macular edema. RESEARCH DESIGN AND METHODS: Retrospective cohort analysis of patients from the Kaiser Permanente Northern California Diabetes Registry who had no evidence of diabetic retinopathy at a baseline diabetic retinopathy screening during 2008–2020 was performed. Machine learning and logistic regression prediction models for onset of proliferative diabetic retinopathy, diabetic macular edema, and referable retinopathy detected through routine screening were trained and internally validated. Model performance was assessed using area under the curve (AUC) metrics. RESULTS: The study cohort (N = 276,794) was 51.9% male and 42.1% White. Mean (±SD) age at baseline was 60.0 (±13.1) years. A machine learning XGBoost algorithm was effective in identifying patients who developed proliferative diabetic retinopathy (AUC 0.86; 95% CI, 0.86–0.87), diabetic macular edema (AUC 0.76; 95% CI, 0.75–0.77), and referable retinopathy (AUC 0.78; 95% CI, 0.78–0.79). Similar results were found using a simpler nine-covariate logistic regression model: proliferative diabetic retinopathy (AUC 0.82; 95% CI, 0.80–0.83), diabetic macular edema (AUC 0.73; 95% CI, 0.72–0.74), and referable retinopathy (AUC 0.75; 95% CI, 0.75–0.76). CONCLUSIONS: Relatively simple logistic regression models using nine readily available clinical variables can be used to rank order patients for onset of diabetic eye disease and thereby more efficiently prioritize and target screening for at risk patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Physiochemical indicator-based DR models were predominantly single-center (75%, 6/8), with only 2 multicenter studies conducted in the United States and Northern Ireland.
“In contrast, physiochemical indicator-based models were predominantly single-center (75%, 6/8), with only 2 multicenter studies conducted in the United States and Northern Ireland [39, 40], reflecting a limited degree of external validation across populations.”
From Artificial intelligence-powered prediction of diabetic complications: from clinical data to molecular omics (2026) · cites this paper as [39]
Data Collection describes a U.S. diabetic-retinopathy prediction study using Kaiser Permanente Northern California records. The Conclusions say validation occurred within the same single health care delivery system and that external validation elsewhere is needed. Our copy does not establish that this was a multicenter study or substantiate the citing sentence’s count of two multicenter studies among eight models. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ipp, E., Liljenquist, D., Bode, B., Shah, V. N., Silverstein, S., Regillo, C. D., Lim, J. I., Sadda, S., Domalpally, A., Gray, G., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34254 · Cited by 256 · see citing works
Stempniewicz, N., Vassalotti, J. A., Cuddeback, J. K., Ciemins, E., Storfer-Isser, A., Sang, Y., Matsushita, K., Ballew, S. H., Chang, A. R., Levey, A. S., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2715 · Cited by 157 · see citing works
Flagged first, then by citations
Research works printed but not linked: 20
- Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 diabetes: demystifying the global epidemic. Diabetes 2017;66:1432-1442
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-1046
- Wilkinson CP, Ferris FL 3rd, Klein RE, et al.; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682
- Yau JW, Rogers SL, Kawasaki R, et al.; Meta- Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556- 564
- Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2015;2:17
- Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology 2004;111:1055-1062
- Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photo- graphy with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002;134: 204-213
- Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 2017;40: 412-418
- Chin EK, Ventura BV, See KY, Seibles J, Park SS. Nonmydriatic fundus photography for tele- ophthalmology diabetic retinopathy screening in rural and urban clinics. Telemed J E Health 2014;20:102-108
- Abr amoff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med 2018;1:39
- Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102: 527-532
- Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859-1868
- Moffet HH, Adler N, Schillinger D, et al. Cohort profile: The Diabetes Study of Northern California (DISTANCE) objectives and design of a survey follow-up of social health disparities in a managed care population. Int J Epidemiol 2009; 38:38-47
- Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, CA, 13-17 August 2016. New York, Association for Computing Machinery, pp. 785-794
- Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36
- Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. New York, Oxford University Press, 2003
- H2O.ai. R Interface for H2O, R package version 3.36.0.4, 2022. Accessed 11 March 2023. Available from https://github.com/h2oai/h2o-3 24. Oh E, Yoo TK, Park EC. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC Med Inform Decis Mak 2013;13:106
- Ogunyemi OI, Gandhi M, Lee M, et al. Detecting diabetic retinopathy through machine learning on electronic health record data from an urban, safety net healthcare system. JAMIA Open 2021;4:b066 26. Bora A, Balasubramanian S, Babenko B, et al. Predicting the risk of developing diabetic retino- pathy using deep learning. Lancet Digit Health 2021;3:e10-e19
- Fong DS, Aiello L, Gardner TW, et al.; American Diabetes Association. Diabetic retinopathy. Diabetes Care 2003;26:226-229
- Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-176
Cited by
Sorted by citations
Xie, X., Wu, C., Huang, Z., Zhou, Y., Huang, J., Dao, F., Yan, D., Deng, K., Lyu, H., Ma, C., et al. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag083 · Cited by 4 · see citing works
“…U.S. study established a predictive model incorporating nine clinical variables including insulin use, age, and BMI, which effectively identifies high-risk ocular complications like PDR, referable retinopathy, and diabetic macular edema, providing decision support for screening prioritization [39].”
- Authors
- Tarasewicz, D., Karter, A. J., Pimentel, N., Moffet, H. H., Thai, K. K., Schlessinger, D., Sofrygin, O., & Melles, R. B.
- Affiliations
- Kaiser Permanente Oakland Medical Center (US)
- Kaiser Permanente (US)
- Corresponding author
- Tarasewicz, Dariusz
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2023-03-17
- Volume
- 46
- Issue
- 5
- Pages
- 1068-1075
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC10257789
- OpenAlex
- W4327697322
- Cited by
- 17
- References
- 2
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 3 · 2023: 2
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIDDK Centers for Diabetes Translational Research (P30 DK092924)
- The Permanente Medical Group Delivery Science Grants Program (RNG 211024)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, risk stratification, proliferative diabetic retinopathy, diabetic macular edema, risk prediction model, XGBoost, logistic regression, diabetes screening
- MeSH terms
- Aged, Algorithms, Blindness, Diabetes Mellitus, Diabetic Retinopathy, Female, Humans, Macular Edema, Male, Middle Aged, Retrospective Studies, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review